Your browser doesn't support javascript.
loading
Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma.
Kondrashova, Olga; Nguyen, Minh; Shield-Artin, Kristy; Tinker, Anna V; Teng, Nelson N H; Harrell, Maria I; Kuiper, Michael J; Ho, Gwo-Yaw; Barker, Holly; Jasin, Maria; Prakash, Rohit; Kass, Elizabeth M; Sullivan, Meghan R; Brunette, Gregory J; Bernstein, Kara A; Coleman, Robert L; Floquet, Anne; Friedlander, Michael; Kichenadasse, Ganessan; O'Malley, David M; Oza, Amit; Sun, James; Robillard, Liliane; Maloney, Lara; Bowtell, David; Giordano, Heidi; Wakefield, Matthew J; Kaufmann, Scott H; Simmons, Andrew D; Harding, Thomas C; Raponi, Mitch; McNeish, Iain A; Swisher, Elizabeth M; Lin, Kevin K; Scott, Clare L.
Afiliación
  • Kondrashova O; Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Nguyen M; Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Shield-Artin K; Clovis Oncology, Inc., Boulder, Colorado.
  • Tinker AV; Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Teng NNH; Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Harrell MI; British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
  • Kuiper MJ; Stanford University, Palo Alto, California.
  • Ho GY; University of Washington, Seattle, Washington.
  • Barker H; Melbourne Bioinformatics, The University of Melbourne, Melbourne, Victoria, Australia.
  • Jasin M; Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Prakash R; Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Kass EM; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Sullivan MR; Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Brunette GJ; Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Bernstein KA; Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Coleman RL; Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Floquet A; Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Friedlander M; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Kichenadasse G; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • O'Malley DM; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Oza A; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sun J; Institut Bergonié, Bordeaux, France.
  • Robillard L; University of New South Wales and Prince of Wales Hospital, Sydney, New South Wales, Australia.
  • Maloney L; Flinders University, Adelaide, South Australia, Australia.
  • Bowtell D; The Ohio State University, James Cancer Center, Columbus, Ohio.
  • Giordano H; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Wakefield MJ; Foundation Medicine, Inc., Cambridge, Massachusetts.
  • Kaufmann SH; Clovis Oncology, Inc., Boulder, Colorado.
  • Simmons AD; Clovis Oncology, Inc., Boulder, Colorado.
  • Raponi M; Clovis Oncology, Inc., Boulder, Colorado.
  • McNeish IA; Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Swisher EM; Melbourne Bioinformatics, The University of Melbourne, Melbourne, Victoria, Australia.
  • Lin KK; Mayo Clinic Cancer Center, Rochester, Minnesota.
  • Scott CL; Clovis Oncology, Inc., Boulder, Colorado.
Cancer Discov ; 7(9): 984-998, 2017 09.
Article en En | MEDLINE | ID: mdl-28588062
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Resistencia a Antineoplásicos / Proteínas de Unión al ADN / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Indoles Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Discov Año: 2017 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Resistencia a Antineoplásicos / Proteínas de Unión al ADN / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Indoles Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Discov Año: 2017 Tipo del documento: Article País de afiliación: Australia